RECOMBINANT VACCINE AGAINST PROLIFERATIVE ENTEROPATHY IN ANIMALS

The present invention relates to a recombinant vaccine against Lawsonia intracellularis, based on a recombinant synthetic chimeric variant of membrane proteins and invasins of said bacteria. In addition, the invention discloses synthetic nucleotide sequences encoding said protein variants, recombina...

Full description

Saved in:
Bibliographic Details
Main Authors MONTESINO SEGUI Raquel, FARNOS VILLAR Omar, HIDALGO GAJARDO Angela, GUTIERREZ MELLA Nicolas, RAMOS DELGADO Eduardo, CORTEZ SAN MARTIN Marcelo, SANCHEZ RAMOS Oliberto, RUIZ GARRIDO Alvaro, TOLEDO ALONSO Jorge
Format Patent
LanguageEnglish
Spanish
Published 05.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a recombinant vaccine against Lawsonia intracellularis, based on a recombinant synthetic chimeric variant of membrane proteins and invasins of said bacteria. In addition, the invention discloses synthetic nucleotide sequences encoding said protein variants, recombinant proteins as such, an expression cassette of said synthetic protein antigens, a transformed cell, and a method for producing said antigens, demonstrating the antigenicity and protective potential thereof against the pathogen Lawsonia intracellularis. La presente invención provee una vacuna recombinante contra Lawsonia intracellularis basada en una variante quimérica sintética recombinante de proteínas de membrana e invasinas de dicha bacteria. Adicionalmente, la invención divulga secuencias nucleotídicas sintéticas que codifican dichas variantes proteicas, proteínas recombinantes como tales, un casete de expresión de dichos antígenos sintéticos proteicos, una célula transformada y un método para la producción de dichos antígenos, demostrando su antigenicidad y potencial protecctivo frente al patógeno Lawsonia intracellularis.
Bibliography:Application Number: MX20200002283